Testosterone Pellets Reviews: What Men Actually Report (and What the Studies Show)
Testosterone pellets reviews in our small Drugs.com sample were mostly positive: 12 of 17 accounts rated treatment 8–10. Six described lasting soreness and five described fading benefit or levels. Pellets may suit men with confirmed low testosterone who want fewer treatment tasks, but adjustment limits, fertility plans and full cost come first.
Pellets are a strong fit for some men and a poor first choice for others, but reviews can't decide your medical fit. The tradeoff: once pellets are in, you can't simply turn the implanted dose down. If a complication means treatment must stop, the label says the pellets would have to be removed. There's also a pattern in the reviews worth asking a clinic about. We'll get to it in a minute.
Pellets may fit you if: symptoms or signs and repeat morning blood tests confirm low testosterone, your clinician has reviewed your response to treatment, and you'd trade a small office procedure every few months for fewer treatment tasks in between. Follow-up still matters.
Look elsewhere first if: you have not had a full low-testosterone evaluation, you may want children, your red blood cell count has run high before, or you want a treatment form your clinician can adjust more easily.
Testosterone pellets at a glance
TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.
Scope: This page covers testosterone pellets for adult men being evaluated or treated for low testosterone (hypogonadism). The Testopel label has no indication for women, and pellets for women raise different questions.
Disclosure: TRT Provider Guide may earn commissions from some providers we link to, including Male Excel. Commercial relationships do not determine our factual findings or editorial conclusions. Read our affiliate disclosure.
If your insertion site is getting more red, hot, swollen or is draining — or a pellet is poking through the skin — call the clinic that placed it today. Chest pain or sudden trouble breathing needs emergency care.
The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use TRT Provider Guide's Find My TRT Path tool to explore online TRT programs, or compare local care options for an in-person starting point. The tool is educational; it does not diagnose low testosterone, determine medical eligibility or guarantee a prescription.
What do testosterone pellets reviews actually say?
Most accounts in our small Drugs.com sample were positive: 12 of the 17 included accounts rated treatment 8 to 10 out of 10. Lasting soreness appeared in six accounts; fading benefit or testosterone levels appeared in five. These are reports, not a measure of how often those problems happen to patients.
Clinic websites are full of glowing testimonials. Forums are full of horror stories. Neither tells you what's typical.
So we did the slow thing. We read all 18 entries displayed on the Drugs.com Testopel review page on October 21, 2026, and recorded the same details from each one. Here's what came out.
Our Testopel review ledger
Source: TRT Provider Guide's coding of Drugs.com Testopel reviews, checked October 21, 2026. Reviews dated 2010 to 2020.
Of the four low ratings, one came from a man writing seven days after his first insertion; the listing gives no later outcome. Two came from men who did well on shots and didn't do as well on pellets. Four accounts mentioned weight gain, including two that rated treatment 1/10. One welcomed the gain; another described gain and weight cycling while still preferring pellets.
The pellet-count pattern
All eight accounts with a complete or reconstructable pellet total reported 10 to 16. One total comes from six covered pellets plus four paid for separately; another account mentioned two added compounded pellets without giving a full total.
The Testopel label's dose guide for men is 150 to 450 mg every three to six months. With 75 mg per pellet, that's 2 to 6 pellets. (Testopel label)
That gap doesn't show whether an individual's treatment was appropriate. Use above the label range appears in published studies; it is off-label dosing. The randomized trial comparing pellet products used 10 Testopel pellets. (Kresch et al., 2023) Your clinician sets your dose, and we're not suggesting one.
The gap raises three questions worth taking to the clinic:
- Insurance limits. UnitedHealthcare's cited commercial policy requires dosing in line with FDA labeling. One historical Medicare reviewer said only 6 of his 10 pellets were covered and reported paying $400 to $500 for the other 4. That is his reported bill, not a current Medicare coverage rule. (UHC policy)
- Wear-off complaints. Some accounts with higher reported pellet counts still described fading around month three. A pellet count does not tell you how long symptom relief will last.
- Less room to back off. More Testopel pellets means more implanted testosterone; the label's warning about limited adjustment still applies.
Ask any clinic two plain questions: "How many pellets are you planning, and why that number?"
Why star ratings for pellets don't line up
You'll see different scores on different sites. That's because they're counting different things.
That's why we built our own count. Excluding that spouse's account leaves 17 apparent first-person pellet accounts: their ratings total 124, giving 124 ÷ 17 = 7.3 after rounding. This is our calculation, not the platform's published score.
One honest limit: 17 reviews is a small group, and the people who post are often the happiest or the most upset. Use these numbers to spot patterns and questions, not to predict your odds. The newest included review is from 2020. These reports do not establish today's prices, labels or insurance rules. We could not verify the writers' identities, diagnoses or exact products; one account describes added compounded pellets and another reports an additional hormone-related drug.
How long do testosterone pellets last?
Testopel's label describes an adequate effect for three to four months, sometimes up to six. By the label's own numbers, about three-quarters of the implanted testosterone is absorbed by the end of month three. That does not predict when your symptoms will change or when another insertion is right for you.
The label spells out how the release works. About one-third is absorbed in the first month. About one-quarter in the second month. About one-sixth in the third. (Testopel label)
Add those up and roughly 75% is gone by the end of month three. What's left releases slowly after that.
So "lasts up to six months" and "mine wore off at three" can both be true; they do not describe everyone's symptom response.
What the studies measured
- A rise, then a decline. In an open-label Testopel study at one center, mean testosterone was above the pre-insertion level at weeks 1, 4 and 12, and returned to that level by week 24. Blood levels and symptom relief are different outcomes. (Kaminetsky et al., 2011)
- Six-month evidence is thin. The randomized pellet trial reported that 82% fell below 300 ng/dL by the end of the study. But only 10 of 75 participants had six-month measurements, and men below the reference range at four months were excluded from the six-month comparison. That headline percentage is not a dependable six-month probability for you, and 300 ng/dL alone is not a diagnosis. (Kresch et al., 2023)
What the pellet timeline evidence shows
This timeline pulls together the label, the studies above and what reviewers described. Your own timeline can differ.
"once it starts to get low, I really get sluggish" — Fra..., Drugs.com, October 14, 2018
One person's experience. Results vary.
If yours wear off early
Don't try to fix it on your own. Tell your clinician when the fade starts. Ask whether they'll check your testosterone level near that point, and whether timing, pellet count or a different treatment form makes more sense for you.
Just had your first insertion?
Here's something worth knowing. In a survey of 382 men on testosterone therapy at one academic clinic, only 39% of men on pellets for less than six months were satisfied. Among men on pellets for six to 12 months, 95% were. Those were different small groups: 7 of 18 satisfied versus 20 of 21. The survey did not follow the same men from an unhappy first round to a better later one, so it cannot show that waiting or dose adjustment caused improvement. (Kovac et al., 2014)
Overall, satisfaction in that survey was about the same for pellets, shots and gels — around 70%. Pellets aren't better. They're different.
What's the biggest downside of testosterone pellets?
The biggest tradeoff is flexibility. Once testosterone pellets are implanted, there is no simple dose adjustment, and the Testopel label says that if treatment has to stop because of a complication, the pellets would have to be removed. A clinician can change future injections or topical treatment without removing an implant, but a dose already given does not disappear at once.
The Testopel label is blunt about this. It says pellets are much less flexible for adjusting the dose than injections or oral forms, so "great care" is needed when choosing the amount. (Testopel label)
In practice, that means:
- If your dose is too high, your clinician needs to assess what to do; waiting it out is not a safe default.
- If your blood count climbs or another side effect shows up, there's no quick off switch.
- If your plans change — say, you decide you want kids — the testosterone keeps releasing.
For a man whose treatment response has been stable on shots or gel, that history can help the clinician plan. It does not make pellet adjustment limits disappear or establish a matching pellet dose. For a man starting testosterone for the first time, the need for a clear monitoring and adjustment plan matters a lot.
Here's where we'll be straight with you about our own business. Male Excel, an affiliate partner of TRT Provider Guide, says it does not offer pellets. (Its statement) If the implant is what you want, a local urologist or pellet clinic is the better fit, and the rest of this page will help you get a good one.
Its injection and cream options do not require an implanted pellet. Male Excel describes 60-day medication supplies and clinician reviews around refills. Ask how to reach the clinician sooner if symptoms or side effects change; do not change the prescription yourself. There's nothing to remove and no pellet procedure every few months. (Program details)
What we actually verified about Male Excel — its public claims, October 21, 2026:
- Testosterone treatment forms: testosterone cypionate injections and testosterone cream. No pellets. These are provider-stated offerings, not treatments we tested.
- A separate non-testosterone option: it also advertises oral Triclozene, which is not testosterone replacement. Its public pages disagree on whether it contains clomiphene or enclomiphene; confirm the exact ingredients and pharmacy in writing. (Pricing page; oral-product page) Clomiphene use in men is off-label, and there is no FDA-approved enclomiphene drug; neither fact turns the advertised compound into an FDA-approved product. (Clomiphene label; FDA on enclomiphene)
- Posted starting charges: $99 for the initial at-home test and consultation; $99 per month for the required medical membership. Its main pricing page lists testosterone with thyroid medication from $120 per month for injections or $132 for cream, in 60-day supplies billed every other month; shipping is extra. These are advertised package prices, not testosterone-only quotes or a recommendation to use thyroid medication. (Male Excel pricing; initial test and consultation)
- Testing and follow-up: the program page advertises assessments every 60 days and blood testing every six months as membership features. That does not confirm that all diagnostic, repeat early-morning or additional monitoring tests are included. Ask for the panel, collection process and any extra charges. (Program details)
- Payment and cancellation: cash pay; Male Excel advertises possible FSA/HSA use. It says "cancel anytime," but its terms provide for automatic recurring charges and generally nonrefundable fees unless a written exception applies. Confirm when cancellation stops the next charge or shipment. (Terms)
- Know before you sign up: Male Excel describes its testosterone as "bioidentical," and its materials describe compounding pharmacy partners. Compounded preparations aren't FDA-approved, so ask for the exact product and pharmacy in writing. Its site also says an in-person exam may be required depending on DEA and state rules. Confirm that the service is available in your state before paying. (FAQ; program disclosures)
Using twelve advertised monthly equivalents and one initial bundle gives $2,727 for the injection-and-thyroid package ($99 + 12 × [$99 + $120]) or $2,871 for the cream-and-thyroid package ($99 + 12 × [$99 + $132]). These are modeled subtotals before shipping and unconfirmed extras, not complete first-year bills. Ask for a written quote showing the actual prescription, all required tests and visits, shipping and charge dates; 60-day supplies and calendar-month billing do not automatically produce the same first-365-day total.
A separate live Male Excel pricing page shows different fees. Confirm which written offer applies before paying; we have not mixed the two offers.
As of October 21, 2026, a federal temporary extension permits some controlled-substance prescribing by telemedicine through December 31, 2026, subject to its conditions and applicable federal and state law. It does not guarantee an online prescription or remove every in-person requirement. (DEA)
Would you rather discuss a treatment form your clinician can adjust without removing pellets? Read our Male Excel injection program guide. A licensed clinician decides whether treatment is right for you. Nothing here guarantees a prescription.
Other online programs we cover, like Hone Health and Taurus Meds, describe other treatment formats; we did not verify a pellet-insertion service on their public pages. For a full side-by-side of the two most common choices, read our testosterone pellets vs injections comparison.
What is getting testosterone pellets like? Pain, recovery and problems
Pellet insertion is a short office procedure: a numbing shot, a small cut, and pellets pushed under the skin of the hip or upper buttock with a hollow tube called a trocar. Six of our 17 review accounts described soreness or bruising lasting days to weeks. Two U.S. Testopel studies reported uncommon site complications, but their rates use different denominators.
A clinician performs the insertion in person. (Testopel treatment information)
What reviewers described, in their words, varied: some called insertion briefly painful and others called it painless. The days after are the annoying part. Several described soreness lasting about a week or longer; one linked the discomfort to sitting. One mentioned a lump that faded over three to four months. One long-term user mentioned scar tissue building up over the years.
How often things go wrong
We pulled the infection and extrusion figures from the studies below and put them side by side. Extrusion means a pellet working its way back out through the skin. Check the denominator: a percentage of patients is not a percentage of procedures.
Two notes. The Biote figures come from a company-reported analysis led by the company's founder, and 85% of its procedures involved women; the table uses its male procedure counts. The older non-U.S. reports involved different settings and methods, but those differences do not prove why rates varied. These studies cannot rank products or clinics by safety. Kelleher recorded extrusions with pus separately from infections without extrusion; the difference in total extrusion rates between its two groups was not statistically significant.
The takeaway: site complications were uncommon in the two U.S. Testopel studies shown. In the 2009 study, none of the patients reported to have followed their aftercare instructions got an infection or lost a pellet. That observation does not prove that aftercare prevents every complication.
Signs to call the clinic about
The Testopel label lists these as signs of infection or a pellet coming out: hardening of the skin, inflammation, bleeding, bruising, drainage, pain, itching, or a pellet pushing through. Most reported cases occurred in the first month, but infection or extrusion can happen later. (Testopel label)
Call the clinic that placed your pellets if any of these get worse instead of better.
Three questions about safe care
- How many pellet insertions have you done, and how often do your patients have a pellet come out?
- What are my activity and bathing rules after insertion, and for how long?
- Who do I call after hours if the site looks wrong?
Testosterone pellet side effects: blood count, fertility and heart health
Pellets share testosterone risks with other forms and add risks at the insertion site; the rates can differ. In one retrospective study, hematocrit crossed the study's 50% threshold in about 35% of pellet users, compared with 67% on injections and 13% on gels. Testosterone can also lower sperm production, and pellets have no simple off switch.
Side effects compared
Label effects from the Testopel prescribing information, revised July 2025.
Fertility: the one risk that hits differently with pellets
Testosterone from outside the body can suppress spermatogenesis, the process of making sperm. That's true for shots and gels too. The difference with pellets is timing. A clinician can change future injections or gel use, but the effect of a dose already taken does not end at once. An implanted pellet keeps releasing unless it is removed or absorbed.
The Endocrine Society recommends against starting testosterone in men planning fertility in the near term. (Endocrine Society guideline) If you may want children, now or later, talk with a urologist or reproductive urologist before anything is implanted. Neither a review nor a treatment plan can promise preserved fertility or when sperm production will recover. Our TRT and fertility guide explains the options.
Heart, prostate and who shouldn't use pellets
- Heart: The July 2025 Testopel label retains language saying long-term cardiovascular safety is not settled. The large TRAVERSE trial found testosterone gel was not worse than placebo for major cardiovascular events in the men studied, and FDA requested removal of boxed-warning language about increased cardiovascular risk in 2025. TRAVERSE studied gel, so it does not establish pellet-specific safety; atrial fibrillation (an irregular heart rhythm), acute kidney injury and pulmonary embolism (a clot in the lungs) occurred more often in its testosterone group. (TRAVERSE, NEJM 2023; FDA, 2025)
- Prostate and breast cancer: The July 2025 Testopel label lists breast cancer and known or suspected prostate cancer as contraindications—reasons not to use the product. A history or suspicion of cancer needs specialist review, not an online format choice.
- Age-related low testosterone: The July 2025 Testopel label says safety and effectiveness for age-related hypogonadism have not been established. The requested 2026 changes below matter, but age or symptoms alone still do not establish a diagnosis.
- Label updates: In 2025, FDA required blood pressure warning changes across testosterone products. On June 18, 2026, it requested removal of the age-related limitation and revisions to prostate-cancer and enlarged-prostate warnings; the proposed prostate-cancer contraindication would be limited to metastatic disease—cancer that has spread. (FDA, 2025; HHS, June 2026) Those requests are not proof that a specific label has changed. The Testopel label we could verify is dated July 2025, so ask your prescriber about the newest version.
Monitoring still matters
Fewer treatments doesn't mean fewer check-ups. Expect your clinician to follow your symptoms, testosterone level, hematocrit, blood pressure and, depending on your age and risk, your prostate-specific antigen (PSA), a blood test used to watch the prostate. (Endocrine Society guideline) The guideline calls for testosterone and hematocrit checks after treatment starts, with later checks based on the treatment and results; hematocrit is generally checked at baseline, three to six months and then annually. Pellet testosterone checks are usually timed near the end of the dosing interval. Our TRT bloodwork guide explains monitoring questions to ask.
Get emergency care for chest pain or sudden shortness of breath. Get prompt medical assessment for a painful, swollen leg. An erection lasting four hours or more needs emergency care; seek help sooner if it is painful and not going down. (NHS emergency guidance)
Testopel vs compounded pellets: does it matter which one you get?
It matters for oversight: Testopel is an FDA-approved testosterone pellet, while compounded pellets are not FDA-approved. A compounding pharmacy prepares a compounded drug; FDA does not review that preparation for safety, effectiveness and quality before marketing. One small trial found similar testosterone levels with one compounded product and Testopel, but that does not establish equivalence or cover every pharmacy's product.
A lot of pellet marketing calls the product "bioidentical" or "plant-derived." Those words describe the shape of the molecule or where it started. They don't mean a product is FDA-approved, and they don't mean it's safer. (FDA on compounded drug risks)
Schedule III means testosterone is a controlled substance under federal law. You need a valid prescription, and the rules for prescribing it are stricter than for most drugs. (Testopel label)
What the head-to-head trial found
Researchers randomly assigned 75 men to either 10 Testopel pellets or 8 compounded 100 mg pellets from Empower Pharmacy. Those are study exposures, not amounts to request for yourself. Testosterone levels were similar among those measured at two, four and six months, but follow-up fell to 62, 60 and 10 men, respectively. Men below the reference range at four months were excluded from the six-month comparison, and the study received grant funding from Empower Pharmacy. (Kresch et al., 2023)
The study does not show that every compounded pellet is worse—or equivalent. Compounded products do not undergo FDA premarket approval, and one study can't vouch for every pharmacy.
How to find out what you're getting
Ask the clinic, and get the answers in writing:
- Is this Testopel or a compounded pellet?
- If compounded, which pharmacy makes it, and what strength is each pellet?
- How many pellets, and what's the total dose?
What about Biote?
Biote describes a network of providers using compounded pellets for women and men. The safety figures discussed here come from the company-reported analysis in the table above. That's useful, but it isn't independent. (Biote; published analysis)
Who are testosterone pellets best for — and who should skip them?
Pellets may fit men with properly confirmed low testosterone who value fewer treatment tasks and accept the procedure, monitoring and limited flexibility. Fertility plans, a history of high hematocrit, an incomplete evaluation or a need for easy adjustment call for a different discussion first. Being new to testosterone does not by itself decide which form is right.
This is our editorial judgment, built from the label, the studies and the review patterns above.
The diagnosis piece matters most. The Testopel label says low testosterone should be confirmed with morning blood tests on at least two separate days before starting. The Endocrine Society says diagnosis should combine symptoms or signs with consistently low results on accurate testing, plus a look for the cause; it recommends repeat early-morning, fasting testing. (Testopel label; Endocrine Society) One low number isn't a diagnosis. The Society reaffirmed this in its July 2026 statement. Untreated severe sleep apnea, uncontrolled heart failure, and a heart attack or stroke within the past six months are among the conditions for which the Endocrine Society recommends against starting TRT; discuss them with your clinician. (Endocrine Society guideline)
Landed in the right-hand column? That's useful to know before you pay for anything. Follow the care route in that row first. If the remaining question is which online programs to research, use Find My TRT Path. It's free, and it's educational. It doesn't diagnose low testosterone, clear contraindications or guarantee a prescription.
Testosterone pellets vs injections: what men who switched say
Ten of our 17 accounts explicitly mentioned prior shots or gel. Six of those ten rated treatment 8–10, one rated it 7 and three rated it 1–3. Two described returning, or planning to return, to injections because injections had worked better for them.
The first two rows reflect the included accounts. Gel transfer is a separate concern described in the Endocrine Society guideline.
"If the shots are working, don't mess it up." — Tom..., Drugs.com, January 29, 2020
One person's experience. Results vary.
A matched comparison published in the Canadian Urological Association Journal measured a related tradeoff, not whether someone doing well on shots should switch. Among 26 men per treatment group, median testosterone in the pellet group rose from 210.8 to 360.5 ng/dL. In the injection group, it rose from 240.8 to about 585 ng/dL. (CUAJ) The pellet group had the smaller rise in that study, though injections came with more blood count increases in other research. These retrospective results do not establish a personal target or prove one form works better for you.
The short version: pellets reduce treatment tasks, and some reviewers preferred how they felt. Injections offer more flexibility; which costs less depends on the full care quote and your coverage. Our full testosterone pellets vs injections comparison walks through the decision.
Are testosterone pellets worth the cost?
Pellets are worth it when they solve a real problem for you — needle fatigue, gel transfer worries, or trouble sticking to a routine — and you can afford the insertion and monitoring schedule your clinician proposes. The bill depends on the product, how many pellets you get, what the clinic bundles, and your insurance.
Five accounts mentioned insurance, and all five rated treatment 9 or 10. One said he wouldn't be on Testopel without it "just because it costs so much." — bkb..., Drugs.com, February 26, 2014
What posted prices look like
At Nebraska Urology's posted 2026 charges, Testopel is $153 per pellet and the insertion is $290.70. (Nebraska Urology 2026 charges) Here's our math:
These quantities illustrate the arithmetic; your clinician selects the amount. These are published unit-charge subtotals, not confirmed self-pay quotes or complete patient bills. The sheet does not establish what tests, visits, other fees, discounts or insurance cost sharing would apply to you.
For WellsRx compounded pellets, Advanced Urology lists $180 for insertion plus $50 per pellet; its pricing page excludes laboratory and pathology charges. (Advanced Urology pricing) That's a different product, so it isn't an apples-to-apples comparison.
Ask the clinician how many insertions and follow-up visits are planned for your first year. Use the two-clinic worksheet below to total the actual quote.
Will insurance pay?
It depends on your plan, your diagnosis and paperwork. A few things we confirmed:
- Aetna's commercial-plan policy (reviewed July 8, 2026) generally requires two confirmed low morning testosterone results for a first approval and excludes low testosterone due to aging alone. (Aetna CPB 0345)
- UnitedHealthcare's commercial medical-benefit policy (effective January 1, 2026) ties Testopel coverage to specific diagnoses and treats compounded pellets separately. (UHC policy)
- The billing code changed in 2026. CMS introduced HCPCS J1073 for testosterone pellet implants effective January 1, 2026, and discontinued S0189. (CMS) If a 2026 claim gets denied, ask the office to check the code before assuming it's a coverage problem. A correct code does not guarantee coverage.
- Manufacturer help: Testopel's maker offers help with benefit checks, prior authorization and appeals at 1-800-897-9006. That's paperwork help, not a discount. (Testopel reimbursement) Its broad coverage claim cites internal data from 2018, so confirm your own plan.
How do you find a good pellet clinic and a fair quote?
Start with your own doctor or a urologist, or search the Testopel prescriber directory. A directory listing doesn't verify credentials, current service or insurance, so confirm those with the office. Bring the same questions to two clinics and compare the written answers.
If a pellet consult also feels like a sales visit, the fix is simple: ask everyone the same questions, and get the prices in writing. If a clinic can't answer, write "unknown." A blank isn't a zero.
The two-clinic pellet worksheet
For the same first 365 days, add the initial evaluation and testing, each planned insertion, required follow-up and labs, and other mandatory fees. Count bundled items once. Treat a credited deposit as payment toward the total, not an additional fee. If a required charge is unknown, record the known subtotal and mark the full first-year total as unconfirmed. Keep insurance estimates separate from cash quotes, and list possible removal or complication costs separately from the routine plan.
Nothing on this worksheet needs your name, birth date or lab results. Keep the clinical answers between you and the clinic.
Ready to talk to someone who places Testopel? Search the Testopel prescriber directory. It's run by the manufacturer, and a listing isn't an endorsement, so confirm the office's current services and your insurance before booking.
Still choosing between a local clinic and other options? Compare local TRT care and the questions to ask before you book.
How we built this page and what we verified
We read the 18 entries displayed on the Drugs.com Testopel review page on October 21, 2026, coded them using the same rules, and checked medical and price claims against the label, primary studies, insurer policies and posted clinic prices. This is research from public sources, not a firsthand treatment review, and it has not been clinically reviewed.
Here's how the review ledger was built. We read all 18 displayed Testopel reviews. We set aside the June 8, 2012 spouse's multi-format/gel account because it did not establish a pellet experience, leaving 17 apparent first-person pellet accounts. For each, we recorded the rating, year, pellet count if given, the treatment form used before, and whether the reviewer mentioned wear-off, lasting soreness, a pellet coming out, infection, insurance or weight change. Anyone can repeat the count from the public page.
We counted fading only when an account described benefit or testosterone levels falling; feeling normal later or reporting a weight cycle did not count. Soreness meant discomfort or bruising lasting days to weeks, not just pain during insertion. A missing symptom was not treated as proof it never occurred. Counts can overlap, and percentages are rounded from 17; pellet-count percentages use the eight accounts with a complete or reconstructable total.
This page follows our method, How We Review TRT Providers, which separates verified facts, provider-stated facts, customer experiences and our own conclusions. Our editorial standards explain sourcing, authorship and review status.
What we actually verified — October 21, 2026
- Checked: the Testopel label (revised July 2025); FDA and HHS testosterone label notices; the Endocrine Society guideline and July 2026 statement; the primary studies and abstracts linked here; four public review listings; Aetna, UnitedHealthcare and CMS documents; posted prices from Nebraska Urology and Advanced Urology; Testopel's reimbursement page and prescriber directory.
- Male Excel (checked October 21, 2026): its public treatment, pricing, testing and program pages, FAQ and terms. Its live pages disagree on prices and the oral product's ingredients; we did not verify a complete personal first-year quote or test the service.
- Provider-stated, not independently confirmed: advertised clinic charges, Male Excel's treatment offerings and membership inclusions, and actual service availability.
- Not confirmed: any individual's insurance coverage, any clinic's full first-year bill, the credentials of a clinician who would treat you, or the exact dispensing pharmacy for a personal prescription.
- Not done: firsthand treatment testing, checkout or enrollment testing, direct support interviews, or clinical review of this page.
Testosterone pellets reviews: frequently asked questions
Pellets raise testosterone in clinical studies, but reviews cannot tell you whether they fit your diagnosis, fertility plans or budget. These answers separate what the label and studies show from what individual reviewers reported.
Do testosterone pellets really work?
Studies show they raise testosterone levels, but symptom benefit varies. In our coding of the Drugs.com listing, 12 of 17 included accounts rated treatment 8 to 10 out of 10; we could not verify who stayed on treatment. The Testopel label describes an adequate effect for three to four months, sometimes up to six.
How long does it take for testosterone pellets to kick in?
In the Kaminetsky study, mean testosterone was above baseline at the week-one measurement. Reviewers reported feeling a change anywhere from a few days to two or three weeks later, and one said about two months. Those anecdotes are not a timetable for your response; tell your clinician about symptoms or side effects instead of assuming you should wait.
How long do testosterone pellets last in men?
The Testopel label says usually three to four months, sometimes up to six. About three-quarters of the dose is absorbed by the end of month three.
What are the downsides of testosterone pellets?
There is no simple dose adjustment after implantation; stopping treatment for a complication may require removal. Some reviewers described fading benefit and days of soreness, a pellet can come out, and testosterone can suppress sperm production.
Can testosterone pellets fall out?
Yes. One U.S. Testopel study reported one extrusion in 292 procedures (0.3%); another reported three affected men among 273 (1.1%) across 501 insertions. Those are different denominators. The label says most reported infection or extrusion cases occurred within the first month.
Can testosterone pellets be removed?
Yes, but it takes a procedure by a clinician. The Testopel label says pellets would have to be removed if treatment needs to stop because of a complication.
Are testosterone pellets FDA-approved?
Testopel is FDA-approved. Compounded pellets are not FDA-approved.
Are testosterone pellets better than injections?
Not better, just different. In one survey, satisfaction was about the same, around 70%, for pellets, shots and gels. Pellets need fewer treatments. Injections are easier for a clinician to adjust; compare complete quotes to know which costs less for you.
Do testosterone pellets cause weight gain?
Four of our 17 accounts mentioned weight gain, including two accounts rated 1/10. Reviews cannot show that pellets caused it or whether the change was fat, muscle or fluid. Pellets aren't approved as a weight-loss treatment.
Can I get testosterone pellets online?
No. Insertion has to happen in person. An online consult can't place pellets, so confirm which office will do the procedure and the follow-up.
Are reviews from women about pellets useful for men?
Not very. Many women's pellet reviews involve different products, doses and goals. Testopel's label covers men.
Who makes Testopel?
The July 2025 Testopel label lists it as manufactured for Endo USA.
The bottom line on testosterone pellets reviews
The 17 accounts we coded were mostly positive, with two honest catches: some described fading benefit, and the days after insertion can be sore. The bigger issue is the one that doesn't show up in star ratings: once pellets are in, there is no simple way to turn the implanted dose down. Fertility plans, follow-up and the full bill still matter.
If your clinician has confirmed the diagnosis and reviewed your treatment response and fertility plans, and you hate needles or gel, pellets can be a great fit. Take the worksheet to two clinics and get it all in writing. If you're new to testosterone or want flexibility, ask your clinician how the other forms compare before choosing an implant.
Still comparing online TRT programs? Use our free Find My TRT Path tool. For pellets, use the local-clinic worksheet and prescriber directory above.
Sources
- Testopel (testosterone pellets) prescribing information, revised July 2025.
- Drugs.com, Testopel user reviews (checked Oct 21, 2026).
- Drugs.com, Testopel for male hypogonadism reviews.
- Drugs.com, Testopel Pellets entry.
- WebMD, testosterone user reviews.
- Kresch E, et al. Compounded vs branded testosterone pellets: randomized trial. Sexual Medicine, 2023.
- Kovac JR, et al. Patient satisfaction with testosterone replacement therapies. Journal of Sexual Medicine, 2014.
- Cavender RK, Fairall M. Testopel single-site safety analysis. Journal of Sexual Medicine, 2009.
- Pastuszak AW, et al. Pharmacokinetic evaluation and dosing of subcutaneous testosterone pellets. Journal of Andrology, 2012.
- Pastuszak AW, et al. Testosterone gels, injections and pellets compared. Sexual Medicine, 2015.
- Kaminetsky JC, et al. A phase IV prospective evaluation of Testopel. Journal of Sexual Medicine, 2011.
- Donovitz GS. Company-reported pellet complication analysis. Therapeutic Advances in Endocrinology and Metabolism, 2021.
- Kelleher S, et al. Antibiotic impregnation of testosterone pellets trial.
- Swinburne J, et al. Testosterone pellet implants audit. Endocrine Abstracts, 2003.
- Canadian Urological Association Journal, erythrocytosis in men on intranasal, injected and pellet testosterone.
- Lincoff AM, et al. TRAVERSE trial. New England Journal of Medicine, 2023.
- Endocrine Society, testosterone therapy guideline.
- Bhasin S, et al. Testosterone therapy in men with hypogonadism (full guideline).
- FDA, class-wide labeling changes for testosterone products, Feb 2025.
- HHS, FDA requests updates to testosterone therapy labeling, June 2026.
- FDA, understanding the risks of compounded drugs.
- Nebraska Urology, 2026 good faith estimate charges.
- Advanced Urology, surgery and procedure pricing.
- Aetna, Clinical Policy Bulletin 0345.
- UnitedHealthcare, testosterone replacement medical benefit policy.
- CMS, HCPCS quarter 3 2025 coding decisions.
- Testopel, reimbursement support.
- Testopel, physician locator.
- Male Excel, HRT costs (checked Oct 21, 2026).
- Male Excel, initial at-home test and consultation.
- Male Excel, online program and membership inclusions.
- Male Excel, terms and conditions, updated July 2026.
- Male Excel, FAQ.
- Male Excel, separate pricing page.
- Male Excel, oral Triclozene product page.
- Male Excel, statement that it does not offer pellets.
- Endocrine Society, testosterone replacement therapy statement, July 16, 2026.
- DEA, fourth temporary telemedicine extension, December 31, 2025.
- NHS, priapism emergency guidance.
- Testopel, cost and coverage source footnotes.
- Clomid prescribing information, DailyMed.
- FDA, Pharmacy Compounding Advisory Committee discussion of enclomiphene, June 2022.
Last verified October 2026. Found something out of date? Tell us and we'll check it.